Jiangsu Hengrui Medicine
600276.SS
#476
Rank
HK$338.19 B
Marketcap
HK$53.02
Share price
-1.63%
Change (1 day)
4.26%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Net assets

Net assets on the balance sheet as of September 2024 : HK$49.21 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company has HK$49.21 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Jiangsu Hengrui Medicine - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$HK$43.51 B-0.03%
2021-12-31$HK$43.52 B18.96%
2020-12-31$HK$36.59 B31.62%
2019-12-31$HK$27.80 B22.54%
2018-12-31$HK$22.68 B18.5%
2017-12-31$HK$19.14 B33.17%
2016-12-31$HK$14.37 B16.07%
2015-12-31$HK$12.38 B21.27%
2014-12-31$HK$10.21 B19.76%
2013-12-31$HK$8.52 B26.04%
2012-12-31$HK$6.76 B25.05%
2011-12-31$HK$5.41 B32.31%
2010-12-31$HK$4.08 B35.18%
2009-12-31$HK$3.02 B31.76%
2008-12-31$HK$2.29 B29.77%
2007-12-31$HK$1.76 B40.13%
2006-12-31$HK$1.26 B18.58%
2005-12-31$HK$1.06 B13.49%
2004-12-31$HK$0.93 B10.77%
2003-12-31$HK$0.84 B10.99%
2002-12-31$HK$0.76 B6.87%
2001-12-31$HK$0.71 B